TWST · Healthcare
Twist Bioscience Corp
35/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
47
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$7.7B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGS
About TWIST BIOSCIENCE CORP
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused…
Who's behind the signal
Every informed buyer we can see on TWST, across all three feeds.
Hedge funds · 8
Duquesne Family Office (Druckenmiller)
New position
Point72 (Steve Cohen)
New position
Citadel Advisors
Increased +3708%
D.E. Shaw & Co
Increased +69%
ARK Invest (Cathie Wood)
Decreased −16%
Baillie Gifford & Co
Decreased −5%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 2 on record
Disclosures from 2020-03-02 to 2022-03-30
The newest disclosure we hold for this stock is 2022-03-30.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-30 | Dwight Evans · D-PA | House | Sold | $1,001 - $15,000 |
| 2020-03-02 | Dwight Evans · D-PA | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
TWIST BIOSCIENCE CORP isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
2
New positions
2
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.6×
% of portfolio
0.3%
Position change
NEW
0.3% of Duquesne Family Office's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
NEW
0.1% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+3708%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+69%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.3×
% of portfolio
2.3%
Position change
−16%
2.3% of ARK Invest's portfolio
Trust weight: 1.4×
% of portfolio
0.1%
Position change
−5%
0.1% of Baillie Gifford & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−77%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−4%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to TWIST BIOSCIENCE CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell TWIST BIOSCIENCE CORP or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订